Cardiology News

WILMINGTON, Del.--(BUSINESS WIRE)--Residents of Delaware County will soon have a new option for around-the-clock emergency and inpatient care closer to home. In early June, ChristianaCare will open ChristianaCare Hospital, Aston, a neighborhood hospital designed to expand access to care in a growing region with increasing health care needs. Download photos. The hospital is expected to care for approximately 15,000 patients each year, or about 40 per day, and will provide 24/7 emergency care, in...

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, has announced its expansion to any cart-based system with the launch of HeartFocus Link. Available now for medical schools, residency, and ultrasound training programs, HeartFocus Link addresses one of the most persistent barriers in cardiac ultrasound education and adoption: the challenge of helping healthcare professionals build confidence and competency using the...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further suppo...

CLICHY, France--(BUSINESS WIRE)--CorWave, a clinical-stage medical company pioneering innovative cardiac assist devices, announces that its Quality Management System has been certified by an independent notified body in accordance with the international ISO 13485 standard. The certification covers the design, development, manufacturing, distribution, and servicing of implantable Left Ventricular Assist Devices (LVADs). This certification marks a foundational regulatory milestone on the path to...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that Palmetto GBA has issued a final Local Coverage Determination (LCD L40205) establishing Medicare coverage guidance for irreversible electroporation (IRE), the non-thermal ablation technology delivered by the Company's NanoKnife System, in...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Coredio, a digital health company developing the first software-as-a-medical-device (SaMD) platform dedicated to heart failure (HF) hemodynamic assessment, today announced that the U.S. Food and Drug Administration has granted its Cardiac Performance Simulation Engine (CPSE™) Breakthrough Device Designation and accepted the platform into the FDA’s Total Product Life Cycle Advisory Program (TAP). CPSE™ is a software-only platform designed to deliver catheter...

CHELMSFORD, Mass.--(BUSINESS WIRE)--From local fields to national venues, youth sports play out every day across the country. Today, ZOLL® Medical, an Asahi Kasei company, announced the next phase of its national Anything Can Happen. Anyone Can Help.™ campaign, aimed at strengthening cardiac emergency readiness where young athletes play. Sudden cardiac arrest remains the leading cause of death among young athletes1, and approximately 356,000 out-of-hospital cardiac arrests occur nationwide each...

SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, maker of the world’s leading smart ring, today announced Oura Ring 5, the smallest smart ring in the world. Built on more than twelve years of industry-leading innovation, Oura delivers its most advanced health sensing and insights in a more comfortable and compact form than ever before. Crafted from lightweight, non-allergenic titanium, Oura Ring 5 goes beyond tracking. Oura pairs its most innovative hardware yet with new software that moves beyond trackin...

ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe presents late-breaking preclinical data supporting STX-1150, a clinical-stage epigenetic silencing therapy...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference in New York and Miami, respectively. Gaurav Shah, M.D., Chief Executive Officer, will take part in a fireside ch...